143: Magnetic resonance imaging (MRI) in patients with non-small cell lung cancer (NSCLC) using active breathing coordinator motion control (Unknown)
- New search for: Kaza, E.
- New search for: Collins, D.
- New search for: Symonds-Tayler, R.
- New search for: McDonald, F.
- New search for: Scurr, E.
- New search for: McNair, H.
- New search for: Hansen, V.
- New search for: Leach, M.
- New search for: Kaza, E.
- New search for: Collins, D.
- New search for: Symonds-Tayler, R.
- New search for: McDonald, F.
- New search for: Scurr, E.
- New search for: McNair, H.
- New search for: Hansen, V.
- New search for: Leach, M.
In:
LUNG CANCER -AMSTERDAM-
;
87
;
S52
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:143: Magnetic resonance imaging (MRI) in patients with non-small cell lung cancer (NSCLC) using active breathing coordinator motion control
-
Contributors:Kaza, E. ( author ) / Collins, D. ( author ) / Symonds-Tayler, R. ( author ) / McDonald, F. ( author ) / Scurr, E. ( author ) / McNair, H. ( author ) / Hansen, V. ( author ) / Leach, M. ( author )
-
Published in:LUNG CANCER -AMSTERDAM- ; 87 ; S52
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2015-01-01
-
Size:S52
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:Unknown
- New search for: 616.99424
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99424 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 87
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
FGFR1 amplification in lung squamous cell carcinoma: A systematic review with meta-analysisJiang, T. / Gao, G. / Fan, G. / Li, M. / Zhou, C. et al. | 2015
- 8
-
EGFR mutation testing in pulmonary adenocarcinoma: Evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsiesScarpino, S. / Pulcini, F. / Di Napoli, A. / Giubettini, M. / Ruco, L. et al. | 2015
- 14
-
HER2 gene mutations in non-small cell lung carcinomas: Concurrence with her2 gene amplification and her2 protein expression and phosphorylationSuzuki, M. / Shiraishi, K. / Yoshida, A. / Shimada, Y. / Suzuki, K. / Asamura, H. / Furuta, K. / Kohno, T. / Tsuta, K. et al. | 2015
- 23
-
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancerOhri, N. / Piperdi, B. / Garg, M.K. / Bodner, W.R. / Gucalp, R. / Perez-Soler, R. / Keller, S.M. / Guha, C. et al. | 2015
- 28
-
Close association of IASLCATSERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomographyNakamura, H. / Saji, H. / Shinmyo, T. / Tagaya, R. / Kurimoto, N. / Koizumi, H. / Takagi, M. et al. | 2015
- 34
-
Pemetrexed in patients with thymic malignancies previously treated with chemotherapyLiang, Y. / Padda, S.K. / Riess, J.W. / West, R.B. / Neal, J.W. / Wakelee, H.A. et al. | 2015
- 39
-
Clinicopathological analysis of pleomorphic carcinoma of the lung: Diffuse ZEB1 expression predicts poor survivalMiyahara, S. / Hamasaki, M. / Hamatake, D. / Yamashita, S.i. / Shiraishi, T. / Iwasaki, A. / Nabeshima, K. et al. | 2015
- 45
-
Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resectionLee, S.H. / Min, J.W. / Lee, J.S. / Kim, C.H. / Yoo, Y.D. / Lee, E.J. / Min, K.H. / Hur, G.Y. et al. | 2015
- 53
-
Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: A prospective multi-institutional study in JapanEguchi, K. / Oyama, T. / Tajima, A. / Abiko, T. / Sawafuji, M. / Horio, H. / Hashizume, T. / Matsutani, N. / Kato, R. et al. | 2015
- 59
-
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims dataFeliciano, J. / Gardner, L. / Hendrick, F. / Edelman, M.J. / Davidoff, A. et al. | 2015
- 65
-
Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST)Rasmussen, J.F. / Siersma, V. / Pedersen, J.H. / Brodersen, J. et al. | 2015
- 73
-
Spontaneous regression of small cell lung cancer combined with cancer associated retinopathyKitai, H. / Sakakibara-Konishi, J. / Oizumi, S. / Hirohashi, Y. / Saito, W. / Kanda, A. / Sato, N. / Nishimura, M. et al. | 2015
- 77
-
Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma casesRusch, A. / Ziltener, G. / Nackaerts, K. / Weder, W. / Stahel, R.A. / Felley-Bosco, E. et al. | 2015
- 80
-
EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: Report of two cases and review of the literatureRicordel, C. / Labalette-Tiercin, M. / Lespagnol, A. / Kerjouan, M. / Dugast, C. / Mosser, J. / Desrues, B. / Lena, H. et al. | 2015
- 85
-
Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinomaSchmid, S. / Siano, M. / Joerger, M. / Rodriguez, R. / Muller, J. / Fruh, M. et al. | 2015
- 89
-
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensusCappuzzo, F. / Moro-Sibilot, D. / Gautschi, O. / Boleti, E. / Felip, E. / Groen, H.J.M. / Germonpre, P. / Meldgaard, P. / Arriola, E. et al. | 2015
- 96
-
Quantification and consequences of lung cancer CT overdiagnosisReich, J.M. / Kim, J.S. et al. | 2015
- 98
-
Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinomaZhao, M. / Zhang, Y. / Zhang, H. / Wang, S. / Zhang, M. / Chen, X. / Wang, H. / Zeng, G. et al. | 2015
- 107
-
Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancerDrzewiecka, H. / Galecki, B. / Jarmolowska-Jurczyszyn, D. / Kluk, A. / Dyszkiewicz, W. / Jagodzinski, P.P. et al. | 2015
- 117
-
Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lungQiong, Z. / Na, W.Y. / Bo, W. / Zhu, Z. / Ling, P. / Bo, M.H. / Min, T.Y. / Lei, Z. / Na, H.D. et al. | 2015
- 122
-
Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testingJurmeister, P. / Lenze, D. / Berg, E. / Mende, S. / Schaper, F. / Kellner, U. / Herbst, H. / Sers, C. / Budczies, J. et al. | 2015
- 130
-
Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance statusWalasek, T. / Sas-Korczynska, B. / Dabrowski, T. / Reinfuss, M. / Jakubowicz, J. / Blecharz, P. / Luczynska, E. / Darasz, Z. / Skotnicki, P. et al. | 2015
- 136
-
A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109)Hattori, Y. / Satouchi, M. / Shimada, T. / Urata, Y. / Yoneda, T. / Mori, M. / Nishimura, T. / Sunadome, H. / Kumagai, T. et al. | 2015
- 141
-
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501Nogami, N. / Takigawa, N. / Hotta, K. / Segawa, Y. / Kato, Y. / Kozuki, T. / Oze, I. / Kishino, D. / Aoe, K. et al. | 2015
- 148
-
Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in KoreaBaek, J.H. / Sun, J.M. / Min, Y.J. / Cho, E.K. / Cho, B.C. / Kim, J.H. / Ahn, M.J. / Park, K. et al. | 2015
- 155
-
Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?Choi, Y.W. / Ahn, M.S. / Jeong, G.S. / Lee, H.W. / Jeong, S.H. / Kang, S.Y. / Park, J.S. / Choi, J.H. / Lee, S.Y. et al. | 2015
- 162
-
Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancerGuo, X. / Li, D. / Wu, Y. / Chen, Y. / Zhou, X. / Wang, X. / Huang, X. / Li, X. / Yang, H. et al. | 2015
- 169
-
The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancerCLICaP / Arrieta, O. / Cardona, A.F. / Corrales, L. / Campos-Parra, A.D. / Sanchez-Reyes, R. / Amieva-Rivera, E. / Rodriguez, J. / Vargas, C. et al. | 2015
- 176
-
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancerDavis, K.L. / Goyal, R.K. / Able, S.L. / Brown, J. / Li, L. / Kaye, J.A. et al. | 2015
- 186
-
The impact of comorbidity upon determinants of outcome in patients with lung cancerScottish Lung Cancer Forum / Grose, D. / Morrison, D.S. / Devereux, G. / Jones, R. / Sharma, D. / Selby, C. / Docherty, K. / McIntosh, D. et al. | 2015
- 193
-
Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registryFlorian, K. / Wolfgang, H. / Andreas, S. / Andreas, P. / Thomas, S. / Richard, G. / Jutta, A. / Meinhard, N.S. / William, S. et al. | 2015
- 201
-
Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case reportMellema, W.W. / Burgers, S.A. / Smit, Egbert.F. et al. | 2015
- 204
-
Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patientTiseo, M. / Bersanelli, M. / Perrone, F. / Tamborini, E. / Settanni, G. / Busico, A. / Rossi, G. / Ardizzoni, A. / Pelosi, G. et al. | 2015
- 207
-
Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patientLu, S. / Azada, M.C. / Ou, S.H.I. et al. | 2015
- 210
-
Corrigendum to ''Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study'' [Lung Cancer 85 (2014) 415-419]the GFPC team / Auliac, J.B. / Chouaid, C. / Greillier, L. / Monnet, I. / Le Caer, H. / Falchero, L. / Corre, R. / Descourt, R. et al. | 2015
- 211
-
Future options for ALK-positive non-small cell lung cancerIacono, D. / Chiari, R. / Metro, G. / Bennati, C. / Bellezza, G. / Cenci, M. / Ricciuti, B. / Sidoni, A. / Baglivo, S. et al. | 2015
- 220
-
Targeting HER2 in the treatment of non-small cell lung cancerMar, N. / Vredenburgh, J.J. / Wasser, J.S. et al. | 2015
- 226
-
Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisalPelosi, G. / Barbareschi, M. / Cavazza, A. / Graziano, P. / Rossi, G. / Papotti, M. et al. | 2015
- 232
-
Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: A systematic review of completed and ongoing studiesChoy, H. / Gerber, D.E. / Bradley, J.D. / Iyengar, P. / Monberg, M. / Treat, J. / Govindan, R. / Koustensis, A. / Barker, S. et al. | 2015
- 241
-
Medical anticancer treatment of lung cancer associated with comorbidities: A reviewSculier, J.P. / Botta, I. / Bucalau, A.M. / Compagnie, M. / Eskenazi, A. / Fischler, R. / Gorham, J. / Mans, L. / Rozen, L. et al. | 2015
- 249
-
TGF-@b-activated SMAD34 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancerYang, H. / Wang, L. / Zhao, J. / Chen, Y. / Lei, Z. / Liu, X. / Xia, W. / Guo, L. / Zhang, H.T. et al. | 2015
- 258
-
Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomasMedjber, K. / Freidja, M.L. / Grelet, S. / Lorenzato, M. / Maouche, K. / Nawrocki-Raby, B. / Birembaut, P. / Polette, M. / Tournier, J.M. et al. | 2015
- 265
-
CpG hypermethylation contributes to decreased expression of PTEN during acquired resistance to gefitinib in human lung cancer cell linesMaeda, M. / Murakami, Y. / Watari, K. / Kuwano, M. / Izumi, H. / Ono, M. et al. | 2015
- 272
-
EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacityYang, Y. / Zhou, X. / Song, X. / Liu, M. / He, W. / Wang, H. / Wu, C. / Fei, K. et al. | 2015
- 278
-
Radiologic-pathologic correlation of mesothelioma tumor volumeArmato, S.G. / Li, P. / Husain, A.N. / Straus, C. / Khanwalkar, A. / Kindler, H.L. / Vigneswaran, W.T. et al. | 2015
- 283
-
Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: Results from propensity score analysisMokhles, S. / Verstegen, N. / Maat, A.P.W.M. / Birim, O. / Bogers, A.J.J.C. / Mokhles, M.M. / Lagerwaard, F.J. / Senan, S. / Takkenberg, J.J.M. et al. | 2015
- 290
-
An updated systematic review of lung chemo-radiotherapy using a new evidence aggregation methodWilliams, M. / Liu, Z.W. / Hunter, A. / Macbeth, F. et al. | 2015
- 296
-
Maintenance chemotherapy in advanced NSCLC: A population-based assessment of eligibilityTong, K.M. / Laskin, J. / Ho, C. et al. | 2015
- 303
-
Prognosis of synchronous and metachronous multiple primary lung cancers: Systematic review and meta-analysisJiang, L. / He, J. / Shi, X. / Shen, J. / Liang, W. / Yang, C. et al. | 2015
- 311
-
Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutationsYeo, C.D. / Park, K.H. / Park, C.K. / Lee, S.H. / Kim, S.J. / Yoon, H.K. / Lee, Y.S. / Lee, E.J. / Lee, K.Y. et al. | 2015
- 318
-
Identification of atypical ATRNL1 insertion to EML4-ALK fusion gene in NSCLCRobesova, B. / Bajerova, M. / Hausnerova, J. / Skrickova, J. / Tomiskova, M. / Dvorakova, D. et al. | 2015
- 321
-
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancerKinehara, Y. / Minami, T. / Kijima, T. / Hoshino, S. / Morimura, O. / Otsuka, T. / Hayama, Y. / Fukushima, K. / Takeuchi, Y. et al. | 2015
- S1
-
3: MicroRNA-31 expression mediates chemoresistance in malignant pleural mesotheliomaMoody, H.L. / Lind, M.J. / Maher, S.G. et al. | 2015
- S3
-
8: Tumour molecular profiling and quantitative detection of circulating biomarkers in patients with lung cancerKarampini, E. / Farah, H. / Mills, G. / Kamal, N. / Tobal, K. / Cane, P. / Muirhead, J. / Pomplun, S. / King, J.E. et al. | 2015
- S4
-
10: Volatile biomarkers for discrimination of lung cancer risk and mutationDavies, M.P.A. / Barash, O. / Jeries, R. / Peled, N. / Ilouze, M. / Hyde, R. / Marcus, M. / Haick, H. / Field, J. et al. | 2015
- S5
-
13: Case and literature review of pemetrexed induced pneumonitisBhattacharya, I.S. / Mawdsley, S. et al. | 2015
- S6
-
16: Case report: a rare tumour in thoracic oncology, frequently misdiagnosed at presentationEvison, M. / Al-Najjar, H. / Crosbie, P. / Chaturvedi, A. / Shah, R. / Booton, R. et al. | 2015
- S8
-
21: How long does it take from referral to a diagnosis of lung cancer?Caprario, C. / Bunclark, K. / Win, T. et al. | 2015
- S9
-
24: Lung cancer as an 'acute presentation' in acute unselected medical admissions at a district general hospital (audit at Kings Mill hospital, November 2013-May 2014)Saini, G. / Roberts, M. / Downer, N. / Kemp, S. / Cox, G. et al. | 2015
- S10
-
27: Diagnostic utility of unbiased circulating-tumour cell capture through negative depletion of peripheral blood cellsFreydin, D.V. / Chudasama, D. / Freidin, M.B. / Leung, M. / Butcher, D.N. / Rice, A. / Montero Fernandez, A. / Nicholson, A.G. / Lim, E. et al. | 2015
- S11
-
29: CT guided wire localisation of suspicious pulmonary lesions; a review of 10 patientsDaly, A. / Kilgarrif, S. / Eaton, D. / Murray, J. / Lawlor, L. / Redmond, K. et al. | 2015
- S12
-
31: High uptake values on PET results in a number of unnecessary lung resections, despite MDT discussion and attempts to obtain tissue preoperativelyMcManus, K. et al. | 2015
- S13
-
33: A tissue diagnosis in PS 3 patients with suspected lung cancer? Safety and diagnostic outcomes with EBUS-TBNAAl-Najjar, H. / Evison, M. / Crosbie, P. / Martin, J. / Barber, P. / Booton, R. et al. | 2015
- S14
-
36: Rapid on site evaluation with oesophageal ultrasound-guided FNA in the diagnosis and staging of metastatic lung cancerObaidee, S. / Tang, W. / Raja, S.V. / McCrudden, R. / Maddox, A.J. / Barlow, A.B.T. et al. | 2015
- S17
-
44: Haemoptysis with a normal chest X-ray - what are the yields of CT and bronchoscopy?Raju, R.S. / Kazmi, N. / Stephens, J. / Delisle, K. / Malhotra, P. / Callister, M. et al. | 2015
- S18
-
46: Operator sensitivity for pleural malignancy at medical thoracoscopyGunatilake, S. / Parker, L. / Bishop, L. / Babu, S. / Clark, R. / Chauhan, A. et al. | 2015
- S20
-
51: MesobanK: quality control of tumour samplesKnight, J. / Moseley, E. / Gittins, J. / Scarci, M. / Rintoul, R.C. / Rassl, D.M. et al. | 2015
- S21
-
54: An evaluation of lysine demethylase family members in malignant pleural mesotheliomaBreslin, M. / Cregan, S. / Wennstedt, S. / Singh, A.S. / Roche, G. / Gao, Y. / Griggs, K. / Kirschner, M.B. / O'Byrne, K.J. et al. | 2015
- S22
-
56: Pleurectomydecortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy and systemic chemotherapy in malignant pleural mesothelioma. Experience in 100 consecutive patientsLang-Lazdunski, L. / Bille, A. / Lal, R. / Landau, D. / Spicer, J. et al. | 2015
- S23
-
58: The prognostic significance of nodal metastatic burden on survival following radical surgery for malignant pleural mesotheliomaSharkey, A. / Fennell, D. / Nakas, A. / Waller, D. et al. | 2015
- S24
-
61: Evolving paradigms in the treatment of advanced lung adenocarcinoma: an audit of first line treatment outcomes over a 7 year periodNeedham, S.E. / Gatfield, E.R. / Geldart, T.R. et al. | 2015
- S25
-
65: Cisplatin vs carboplatin in adjuvant NSCLC chemotherapyHaridass, A. / Eswar, C.V. / Wong, H. et al. | 2015
- S26
-
67: A retrospective audit of adjuvant chemotherapy in stage Ib-IIIb non small cell lung cancer - the Northern Ireland experience 2004-2012Campbell, L. / Davidson, C. / Devlin, M. / Scullin, P. et al. | 2015
- S28
-
73: Oligo-recurrence on tyrosine kinase inhibitors: is radiotherapy an option?Davies, R.S. / Bowden, C. / Nelmes, D. / Butler, R. / Lester, J.F. et al. | 2015
- S29
-
75: The use of gefitinib and erlotinib in locally advanced and metastatic EGFR mutant lung cancer - assessment of progression free survival according to mutation typeAtkinson, C.E.L. / Owczarczyk, K. / Dickson, J. / Maddox, A.J. et al. | 2015
- S30
-
78: Complete pathological response after TK-inhibitor therapy in adenocarcinoma of the lung. The role of surgerySolli, P. / Caruana, E. / Abah, U. / Granato, F. et al. | 2015
- S32
-
83: A review of the first 10 months of screening selected patients for the ALK translocation using immunohistochemistry, and their subsequent treatmentViola, P. / Popat, S. / Khan, O. / Moule, R. / Polychronis, A. / Stokoe, J. / Dickson, J. / Montero Fernandez, A. / Amat Villegas, I. et al. | 2015
- S33
-
86: The impact of age, performance status and co-morbidities in determining treatment options in elderly patients with non-small cell lung cancer (NSCLC) in Newcastle upon Tyne NHS trust (NUTH)Suthermaraj, G. / Greystoke, A. et al. | 2015
- S36
-
97: New approaches to lung cancer careBall, H. / Trehy, R. / Brimacombe, C. / Cowee, D. et al. | 2015
- S37
-
101: Increasing input from research nurse and lung CNS improves recruitment to clinical trialsClayton, K.J. / Creech, L. / Townley, B. / Iyer, S. / Sheikh, H.Y. et al. | 2015
- S38
-
104: An assessment of patient and doctor views of performance status in outpatient lung cancer patientsTeh, H.P. / Phillips, S. / Russell, C. / Wilding, M. / Ghafoor, Q. et al. | 2015
- S39
-
107: Lung cancer - You can avoid it, get it, survive it; an evaluation of the Irish Cancer Society's annual lung cancer awareness campaign from 2011 to 2013McNamara, A. / Deegan, A. et al. | 2015
- S40
-
111: Are your lung cancer patients missing out on compensation? The importance of documenting asbestos exposure and occupational historyTisi, S. / Dickson, J. / Lawson, M. et al. | 2015
- S41
-
114: Early endobronchial intervention to maintain performance status for oncological therapy: a case seriesGriffin, L. / Andrews, M.L. / Ghosal, R. / Collier, G. et al. | 2015
- S42
-
117: Treatment and survival trends in patients with advanced stage NSCLC: a population based studyJones, G.S. / Khakwani, A. / Hubbard, R. / Baldwin, D.R. / Peake, M. / O'Dowd, E.L. et al. | 2015
- S43
-
119: An investigation of low lung cancer histological completeness rates in a large UK hospital trustO'Donnell, P. / Lord, R. / Banks, T. et al. | 2015
- S45
-
125: LUCADA and median survival in lung cancerCaprario, C. / Bunclark, K. / Win, T. et al. | 2015
- S46
-
128: Experience of lung stereotactic ablative body radiotherapy (SABR) in a non-academic cancer centre in the UKShahid Iqbal, M. / Cyriac, A. / Aynsley, E. / Shakespeare, D. / Richmond, N. / Walker, C. / Piling, K. / Peedell, C. et al. | 2015
- S47
-
131: Optimisation of stereotactic ablative body radiotherapy (SABR) planning: the Hull methodTambe, N.S. / Colley, W.P. / Beaumont, A.K.E. / Beavis, A.W. et al. | 2015
- S48
-
134: Simultaneous cone beam computed tomography (SCBCT) acquisition during volumetric modulated arc therapy (VMAT) for stereotactic ablative radiotherapy (SART): a clinical quality assurance method with simultaneous and periradiotherapy CBCT-IGRTAznar-Garcia, L. / Morenc, A. / Sridhar, T. / Ahmed, S. et al. | 2015
- S49
-
136: Review of CT imaging following stereotactic ablative radiotherapy for stage 1 non small cell lung cancerPascoe, A.C. / Foweraker, K. / Esler, C. / Morgan, S. et al. | 2015
- S51
-
142: IMRT for treating lung cancer - our experience at Northampton General HospitalVaidya, D. / Acquah, H. / Guinee, L. / York, C. / Whilde, N. / Blackmore, A. / Duggleby, S. / Yusof, H. / Jackson, A.H. et al. | 2015
- S52
-
144: A single centre's experience of toxicity, compliance and survival in patients with stage III locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemo-radiotherapy (CCTRT)Hague, C. / Ashcroft, L. / Bayman, N. / Blackhall, F. / Burt, P.A. / Coote, J.H. / Fenemore, J. / Harris, M.A. / Lee, L.W. et al. | 2015
- S54
-
151: A UK survey of the practice of re-irradiation of locally relapsed lung cancers after previous thoracic radiotherapyGhosal, N. / McAleese, J. / Hannah, G. / Hoare, Z. / Bastable, A.J.M. / Lester, J.F. / Brewster, A. / Stuart, N. / Hatton, M.Q. et al. | 2015
- S55
-
154: Positron emission tomography derived parameters as predictive factors for doubling time of tumour & survival in non-small cell lung cancer patients treated with radical radiotherapyKhan, M.H. / Chetiyawardana, A. / Amir, R. / Harrop, V. / Sharma Sharma, K. et al. | 2015
- S56
-
156: Outcome for performance status 2-3 patients undergoing hypo-fractionated radical radiotherapy for NSCLCHsu, J.K. / Horsley, A. / McPartlin, A. / Pemberton, L. / Bayman, N. / Burt, P.A. / Chittalia, A.Z. / Coote, J.H. / Faivre-Finn, C. et al. | 2015
- S57
-
159: Neutropenic sepsis in patients receiving chemotherapy for small cell lung cancerChauhan, M. / Ma, N. / Ahmed, S. et al. | 2015
- S58
-
162: Review of SCLC timelines to assessment and treatment in Northern IrelandMcAleese, J. / Scullin, P. / Johnston, R. et al. | 2015
- S59
-
164: Hyponatraemia in small cell lung cancerWood, G.E. / Yeoh, C. et al. | 2015
- S60
-
166: REST - a DutchUK randomized phase III trial on the use of thoracic radiotherapy in extensive stage small-cell lung cancerFaivre-Finn, C. / Hatton, M.Q. / Snee, M. / Jain, P. / Wilson, P. / McMenemin, R. / Peedell, C. / Bates, A. / Garcia, A. et al. | 2015
- S61
-
168: Endobronchial cryotherapy in the management and palliation of malignant airway diseaseRyan, S.A. / Eaton, D. / Redmond, K. et al. | 2015
- S62
-
170: Novel thoraco-abdominal analysis technology can measure early respiratory changes following lung cancer resectionElshafie, G. / De Boer, W. / Steyn, R. / Bishay, E. / Kalkat, M. / Rajesh, P. / Wilson, R. / Naidu, B. et al. | 2015
- S63
-
173: Uniportal VATS anatomical resection for NSCLC; is it worth the pain?Anderson, M. / Greco, R. / Folukoya, D. / Edwards, J. / Rao, J. / Socci, L. et al. | 2015
- S65
-
178: Systematic lymph node sampling at operation results in more node positive staging in NSCLCWhiteley, J. / Beattie, G. / McKay, A. / Kirk, A.J.B. / Asif, M. et al. | 2015
- S67
-
182: RESPECT-Meso: a multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesotheliomaGunatilake, S. / Marshall, L. / Chauhan, A. et al. | 2015
- S68
-
184: Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility studyGroom, N. / Tsang, Y. / Hatton, M.Q. / Hanna, G. / Franks, K. / Harden, S. / McDonald, F. / Harrow, S. / Faivre-Finn, C. et al. | 2015
- S69
-
187: National Lung Matrix Trial: multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancerMiddleton, G. / Billingham, L. / Crack, L. / Popat, S. / Walker, I. et al. | 2015
- S70
-
189: Lung ART: phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvementFaivre-Finn, C. / Le Pechoux, C. / Edwards, J. / Lunt, C. et al. | 2015
-
1: Circulating tumour cells from small cell lung cancer patients are tumourigenicHodgkinson, C. / Morrow, C. / Tugwood, J. / Li, Y. / Metcalf, R. / Rothwell, D. / Trapani, F. / Burt, D. / Simpson, K. et al. | 2015
-
4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancerBaird, A.M. / Godwin, P. / Heavey, S. / Barr, M. / Umezawa, K. / Cuffe, S. / Finn, S. / O'Byrne, K.J. / Gately, K.A. et al. | 2015
-
23: LUCADA - are we doing better than the data suggests?Fuller, J. / Killen, J.W. et al. | 2015
-
38: Diagnostic rate of physician performed cutting needle pleural biopsyAnwar, N. / Bibi, A. / Grech, P. / Wilson, S. et al. | 2015
-
42: Are we correctly diagnosing clinical lung cancer?Smith, S. / Magee, N. / Warke, T.J. et al. | 2015
-
115: Exploring the incidence of venous thromboembolism amongst thoracic oncology outpatients; time for thromboprophylaxis?Samani, A. / Dhar, S. / Kh, A.M. / Win, T. et al. | 2015
-
167: Thoracic radiotherapy in extensive stage small cell lung cancerHarris, M.A. / Holland, P. / Hogley, R. / Burt, P.A. / Faivre-Finn, C. / Bayman, N. / Pemberton, L. / Lee, L.W. / Coote, J.H. et al. | 2015
-
177: Lymph node staging for lung cancer in a new VATS lobectomy programme; compliance to ESTS guidelines and stage migration from PET scanAbah, U. / Kadlec, J. / Van Leuven, M. / Bartosik, W. / Van Tornout, F. et al. | 2015
-
14: Radiological demonstration of successful correction of post-pneumonectomy syndrome facilitated by intrathoracic breast implantsIdris, L.O. / Kimpton, J. / Teh, E. / Cogswell, L. / Brant, J. / Matti, S. / Belcher, E. / McKinlay, K. et al. | 2015
-
12: A novel investigation of ERK phosphostatus in non-small cell lung cancerHarrison, R.C. / Aspinall-O'Dea, M. / Walker, M. / Crosbie, E. / Whetton, A.D. / Crosbie, P. et al. | 2015
-
15: Treatment of bilateral synchronous lung cancer in high risk patients: the role of single-port VATS approach and perioperative rehabilitationZakeri, R. / Martin, K. / Socci, L. et al. | 2015
-
34: Rapid on site evaluation (ROSE) accurately identifies carcinoma in patients undergoing diagnostic endobronchial (EBUS)oesophageal (EUS) ultrasound for suspected lung cancerTang, W. / Maddox, A.J. / Barlow, A.B.T. / Obaidee, S. et al. | 2015
-
62: Toxicity and efficacy of oral vinorelbine and carboplatin compared with gemcitabine and carboplatin in metastatic NSCLCSayers, I.G. / Booth, S.C. / Harris, J.M. et al. | 2015
-
66: Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidityWood, S. / Li, R. / Beesley, S. / Brown, J. / Cominos, M. / Hall, J. / Sevitt, T. / Shah, R. / Taylor, H. et al. | 2015
-
80: Potential impact of moving to up-front ALK testing in patients with non small cell lung cancer (NSCLC); the Newcastle upon Tyne NHS Foundation Trust (NUTH) experienceLambourne, B. / Black, F. / Hughes, A. / Gardiner, J. / Cuthbert, G. / Greystoke, A. et al. | 2015
-
103: An exploratory study into the supportive care needs of lung cancer patients at diagnosisPeat, N. / Acworth, N. / Jones, G. / Lal, R. et al. | 2015
-
133: Retrospective audit of treatment outcomes and follow up patterns in patients with non-small cell lung cancer (NSCLC) treated with SABR in South WalesHolloway, J. / Brewster, A. / Button, M. / Lester, J.F. / Tanguay, J. / Shaw, P. / Hanna, L. / Stevens, R. / Bryant, A. et al. | 2015
-
138: Cyberknife(R) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre - results of the first year of treatment at BirminghamStevenson, R. / Harrop, V. / Heyes, G. / Howard, H. / Simmons, R. / Kapadia, A. / Mitchell, T. / Ghafoor, Q. et al. | 2015
-
140: Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) - a feasibility studyFaivre-Finn, C. / Falk, S. / Franks, K. / Hanna, G. / Harden, S. / Harrow, S. / Hatton, M.Q. / McDonald, F. et al. | 2015
-
155: Predictors of failure for PS2-3 patients undergoing hypo-fractionated radical radiotherapy for NSCLC - experience of a UK centreHorsley, A. / Hsu, J.K. / McPartlin, A. / Bayman, N. / Faivre-Finn, C. / Chittalia, A.Z. / Burt, P.A. / Coote, J.H. / Lee, L.W. et al. | 2015
-
185: The SPECIAL trial: exploring the place of early specialist palliative care in UK lung cancer managementAhmedzai, S.H. / Milroy, R. / Billingham, C. / Ryan, T. / Young, T. / Gath, J. / Stubbs, C. / Pope, A. et al. | 2015
-
30: Can chest physicians perform CT biopsy? What factors influence diagnostic success and complications?James, F. / Andrews, M.L. / Ap Emyr, D. / Ghosal, R. / Collier, G. et al. | 2015
-
41: Audit of 'non-small cell lung cancer not - otherwise specified' diagnoses within the Northern Lung Cancer NetworkMcBrearty, C.T. / Williamson, S. / Killen, J.W. et al. | 2015
-
48: The safety profile of VATS pleural biopsyVozza, A. / Stamenkovic, S. / Forty, J. et al. | 2015
-
77: Are EGFR (epidermal growth factor receptor) mutant lung cancers neurotropic and pleurotropic?Bulusu, V.R. / Jessop, S. / Jeffs, Y. / Egan, A. / Prasad, B. / Adu Poku, K. / Sa'D, A. / Thomas, E. / Azher, M. et al. | 2015
-
92: Understanding and reducing admissions to A&E; the role of the lung cancer nurse specialistWalton, D. / Beattie, V. / Roberts, J. / Guerin, M. / Harrison, A. / Rowe, T. / Sarah, M. / Everson, R. et al. | 2015
-
91: Paronychia side effects of targeted therapies and their managementDickson, J. / Munson, J. et al. | 2015
-
93: Using your voice - how to use your nursing voice at the MDTMagee, L.R.A. / Roberts, J. / Beattie, V. / De Normanville, C. / Borthwick, D. et al. | 2015
-
102: Prospective assessment of incident respiratory symptoms in COPD (PAIRS-COPD): a feasibility studyBrummell, S. / Tod, A.M. / Rogers, T. / Bowen, D. / Boon, M. et al. | 2015
-
112: Performance status (PS): is there a correlation between doctor and patient?Clayton, K.J. / Cannon, K. / Creech, L. / Iyer, S. / Babores, M. et al. | 2015
-
127: An audit of online cone beam CT (CBCT) verification data for stereotactic ablative radiotherapy (SABR)Mendes, R. / Allington, L. / Carnell, D. / Haji, N. / Osborn, K. et al. | 2015
-
175: From zero to sixty-seven percent, from one consultant to all. What to expect next? Review of VATS lobectomy programme in Norfolk and Norwich University HospitalKadlec, J. / Abah, U. / Van Leuven, M. / Van Tornout, F. / Bartosik, W. et al. | 2015
-
18: Syndrome of inappropriate antidiuretic hormone (SIADH) management in small cell lung cancer (SCLC); patient's narrative and oncologist's perspective, a case reportJeffs, Y. / Bulusu, V.R. / Jessop, S. / Barclay, C. et al. | 2015
-
20: The importance of a well organised and appropriate referral pathway for the management of gastrointestinal incidental findings on PET-CT done for lung cancerJohnstone, J.R. / David, A. / Morgan, A. / Brookes, M. et al. | 2015
-
25: Lung cancer survivorship clinicWhite, J. / Ashcroft, A. / Callister, M. / Dixon, S. / Adams, M. / Sajjad, B. / Robson, J. / Brunelli, A. et al. | 2015
-
55: Contrast-enhanced magnetic resonance imaging as a marker of tumour angiogenesis in malignant pleural mesotheliomaTsim, S. / Humphreys, C.A. / Stobo, D. / Foster, J.E. / Woodward, R. / Dick, C. / Blyth, K.G. et al. | 2015
-
59: Maintenance pemetrexed immediately following induction treatment with pemetrexed plus cisplatin for advanced non-small-cell non-squamous carcinoma of the lung - a single institution experienceKim, D. / Gilani, S.N. / Giridharan, S. / Sule-Suso, J. / Jegannathen, A. et al. | 2015
-
81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastasesGettinger, S.N. / Bazhenova, L. / Salgia, R. / Langer, C.J. / Gold, K.A. / Rosell, R. / Shaw, A.T. / Weiss, G.J. / Narasimhan, N.I. et al. | 2015
-
82: Can CEA or other tumour markers be useful to monitor ALK-translocation bearing adenocarcinoma of the lung?Crawford, M. / Longden, S. / Waddington, C. / Jeyasangar, G. et al. | 2015
-
116: Predictors of distress in lung cancer patients: a systematic reviewMcHugh, R.S. / Cousins, M. / Macdonald-Smith, C. / Hulbert-Williams, N. et al. | 2015
-
130: Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): initial outcomes from 2 years' experience at the Oxford Cancer Centre, Oxford University Hospitals NHS TrustHill, E. / Higgins, G. / Vallis, K. / Stuart, R. / Drummond, L. / Buckle, A. / Panakis, N. et al. | 2015
-
132: Implementation of stereotactic ablative body radiotherapy (SABR) for early stage medically inoperable lung cancer: an experience from a medium size clinical centreTambe, N.S. / Colley, W.P. / Marsden, J.E. / Beavis, A.W. / Wieczorek, A. / El-Mahdawi, N. et al. | 2015
-
152: 25 Gy in 5 fractions in one week as palliative radiotherapy in NSCLCJones, S. / Pope, A. / Kelly, V. / Maguire, J. et al. | 2015
-
172: VATS lobectomy: the new standard for surgical resection of lung cancer?Asadi, N. / Jordan, S. / Raubenheimer, H. / Niwaz, Z. / Beddow, E. / Anikin, V. / Dusmet, M. / Ladas, G. / McGonigle, N. et al. | 2015
-
176: Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trialsMcElnay, P.J. / Choong, A. / Jordan, E. / Song, F. / Lim, E. et al. | 2015
-
5: Mechanisms of resistance to dual PI3K-mTOR inhibition in NSCLC cell linesHeavey, S. / Dowling, P. / Barr, M. / Cuffe, S. / Finn, S. / O'Byrne, K.J. / Gately, K.A. et al. | 2015
-
57: Are we over-extended in the surgical treatment of mesothelioma? - The tale of the unnecessary phrenectomySharkey, A. / Nakas, A. / Waller, D. et al. | 2015
-
60: Discontinuation of maintenance pemetrexed (mPEM) in non-small cell lung cancer (NSCLC) due to renal failureCharlton, P. / Karapanagiotou, E. / Montes, A. / Spicer, J. / Lal, R. et al. | 2015
-
63: Comparative toxicity profiles of two platinum doublets: real life experience from a cancer unitJessop, S. / Jeffs, Y. / Thomas, E. / Azher, M. / Adu Poku, K. / Sa'D, A. / Prasad, B. / Egan, A. / Bulusu, V.R. et al. | 2015
-
68: Surgical resection and adjuvant chemotherapy in non small cell lung cancer (NSCLC): a review of practice in South East WalesEvans, R. / Johns, E. / Button, M. / Brewster, A. / Hanna, L. / Lester, J.F. / Tanguay, J. et al. | 2015
-
72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East EnglandMargetts, J. / Smith, E. / Aynsley, E. / Gardiner, J. / Hughes, A. / Jones, C. / Li, L. / Mansy, T. / McDonald, F. et al. | 2015
-
76: Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI)Aitken, K. / Popat, S. / Nutting, C. / McDonald, F. et al. | 2015
-
105: Guideline for patient information on enhanced recovery in thoracic surgeryMitchell, J. et al. | 2015
-
126: Our experience in treating lung tumours using stereotactic ablative body radiotherapy (SABR) at Northampton General HospitalYusof, H. / Gore, A. / Mak, C.I. / Eldeeb, H. / Vaidya, D. / Acquah, H. / Whilde, N. et al. | 2015
-
148: Venous thromboembolism associated with enhanced survival for patients undergoing concurrent chemoradiation (55 Gy20f4w plus cisplatinum and vinorelbine) for inoperable NSCLCJones, S. / Kelly, V. / Maguire, J. et al. | 2015
-
179: Falling surgical resection rates; how accurate is LUCADA?Shiferaw, D. / Martin, G. / Blaxill, P. et al. | 2015
-
181: Resection rates in non-small cell lung cancer: how are we doing?Bunclark, K. / Caprario, C. / Win, T. et al. | 2015
-
28: Brain metastases are uncommon in early tumours (T1a, T1b, N0) treated radically by VATS lobectomy, making routine brain imaging unnecessary in this groupMcManus, K. et al. | 2015
-
32: A proposal for minimum quality standards for EBUS-TBNA outcomesEvison, M. / Al-Najjar, H. / Crosbie, P. / Martin, J. / Barber, P. / Booton, R. et al. | 2015
-
40: Do histology 'not otherwise specified' rates influence survival?Caprario, C. / Bunclark, K. / Win, T. et al. | 2015
-
39: Mutation analysis and association with TTF1 expression in lung non-squamous NSCLCKret, A. / Clark, C. / Tennant, S. / Nicolson, M. / Kerr, K.M. et al. | 2015
-
71: Audit of the epidermal growth factor tyrosine kinase (EGFR) and anaplastic lymphoma kinase (ALK) mutation request pathway in non-squamous non-small cell lung cancer (NSCLC) in KentTaylor, H. / Shah, R. / Mccormick, G. / Burcombe, R. / Beesley, S. / Cominos, M. / Hall, J. / Sevitt, T. et al. | 2015
-
74: TRANSCRiPT: a study to assess Tarceva(R) in NSCLC with epidermal growth factor receptor mutationsLewanski, C. / Hennig, I.M. / Muthukumar, D.M. / Benepal, T. / Tahir, S. / Garcia, A. / Summerhayes, M. / De Queiros, S.K. et al. | 2015
-
94: Prospective audit of smoking cessation and lung cancer nurse specialist intervention within the Papworth Thoracic Oncology ServiceKing, M. / Nicol, E. / Magee, L.R.A. et al. | 2015
-
98: Changes in the lung cancer nurse specialist referral criteria for inpatients with a suspected lung cancer diagnosisHughes, J. / Maddock, N. et al. | 2015
-
106: A qualitative study to explore carer perception and experience of end of life care following an individual's death from mesotheliomaDarlison, L. / Geary, M. / Brown, J. et al. | 2015
-
113: Do standardised uptake values from PET-CT scans predict EGFR status of lung tumours?Coote, J.H. / Burt, P.A. / Rimmer, C.R. / Bayman, N. / Blackhall, F. / Califano, R. / Chittalia, A.Z. / Faivre-Finn, C. / Harris, M.A. et al. | 2015
-
135: Intra-fractional tumour motion and an isotropic margin: lung stereotactic ablative body radiotherapy treatment - practice evaluationChauhan, S. / Clarke, L.J. / Stratford, J. / Bewley, M. / Choudhury, A. / Faivre-Finn, C. / Marchant, T. et al. | 2015
-
146: Therapeutic advantage of concurrent chemoradiotherapy with 55 Gy20 fractions with cisplatinum and vinorelbine assessed by comparing control rates predicted by radio-biological (Biosuite) software and clinical resultsMaguire, J. / Uzan, J. / Kelly, V. et al. | 2015
-
50: Outcomes of patients with malignant pleural mesothelioma treated with first line palliative cisplatin and pemetrexed chemotherapy, in South YorkshireTaylor, F. / Viggars, A. / Daniels, S. / Danson, S.J. / Fisher, P.M. / Hatton, M.Q. / Lee, C.E. / Woll, P.J. et al. | 2015
-
70: Molecular analysis in advanced NSCLC are we doing the best we can?Davies, R.S. / Smith, C. / Butler, R. / Parry, D. / Lester, J.F. et al. | 2015
-
84: Quality of life measures relating to the skin toxicities of tyrosine kinase inhibitor (TKI) use in lung cancer - what is in current use in the literature?Watts, G.J. / Nelson, A. / Lester, J.F. / Noble, S.I. et al. | 2015
-
109: Midterm pulmonary function follow up in patients with lung cancer radiofrequency ablationSkondras, E. / Beeson, J. / Dalal, P. et al. | 2015
-
137: Mentorship, development and implementation of SABR for NSCLC: the Bristol experienceMason, J. / Kinsman, J. / Comins, C.J. et al. | 2015
-
165: A retrospective survey of outcomes for patients diagnosed with small cell lung cancer in LeicesterChauhan, M. / Ma, N. / Ahmed, S. et al. | 2015
-
11: Application of SureSeq solid tumour panel sequencing to a panel of FFPE samples of non small cell lung cancer from the Liverpool lung projectHyde, R. / Davies, M.P.A. / Gosney, J. / Field, J. et al. | 2015
-
37: The added value of positron emission tomography to a clinical prediction model for pulmonary nodulesAl-Ameri, A. / Malhotra, P. / Thygesen, H. / Vaidyanathan, S. / Karthik, S. / Scarsbrook, A. / Plant, P. / Callister, M. et al. | 2015
-
52: Review of malignant pleural mesothelioma patients receiving chemotherapy in Northern Ireland 2008-2012Forde, C. / Hamilton, A. / Gallagher, P. / Campbell, L. / Scullin, P. et al. | 2015
-
121: Place and cause of death in patients with lung cancer in the United KingdomO'Dowd, E.L. / McKeever, T. / Baldwin, D.R. / Anwar, S. / Hubbard, R. et al. | 2015
-
124: Electronic cigarette use and risk perception in a Stop Smoking Service in EnglandSherratt, F. / Marcus, M. / Robinson, J. / Newson, L. / Field, J. et al. | 2015
-
139: Assessment of radiation induced gross target volume (GTV) changes using weekly cone-beam CT (CBCT) for NSCLCDuffton, A. / Lamb, C. / McJury, M. / Harrow, S. et al. | 2015
-
147: Audit of chemoradiotherapy (CRT) in locally advanced non-small cell lung cancerWong, S.L. / Morley, T. / Meng, K. / Mahmood, W. / Forster, M. / Mendes, R. et al. | 2015
-
174: Validation of a surgical predictive score for 90 day mortality in lung cancer and comparison with ThoracoscoreO'Dowd, E.L. / McKeever, T. / Baldwin, D.R. / Anwar, S. / Hubbard, R. et al. | 2015
-
2: Platinum-induced DNA damage and repair mechanisms in non-small cell lung cancerHe, Y. / O'Byrne, K.J. / Cuffe, S. / Finn, S. / Barr, M. et al. | 2015
-
6: CeO^2 nanoparticles conjugated with small molecule MET kinase inhibitor reduces the biological activity of human malignant pleural mesothelioma cell linesMohamed, B.M. et al. | 2015
-
35: Rapid on site evaluation (ROSE) may reduce total number of passes needed to achieve definitive diagnosis in endobronchial (EBUS)oesophageal (EUS) ultrasound for suspected lung cancerTang, W. / Obaidee, S. / Barlow, A.B.T. / Maddox, A.J. et al. | 2015
-
43: The impact of a national public awareness campaign for cough as a lung cancer symptomIronmonger, L. / Ohuma, E. / Ormiston-Smith, N. / Gildea, C. / Thomson, C.S. / Peake, M. et al. | 2015
-
47: New pleural service - a first reviewPhitidis, M.E. / Kwok, A. / Denton, C. / Grundy, S. / Chakrabarti, B. / Tippett, V. et al. | 2015
-
45: Medical thoracoscopy: outcomes and complications of procedures carried out over a 12 month periodTedd, H. / McBrearty, C. / Parker, S. / Bourke, S. / Peel, E.T. / Cooper, D. et al. | 2015
-
90: Improving survivorship through pre-habilitation at the start of the journey for lung cancer and mesotheliomaClayton, K.J. / Beattie, V. / Roberts, J. / Hodges, D. / Draffen, J. / Guerin, M. / McIver, A. / Creedon-Wilkes, J. / Bridges, K. et al. | 2015
-
143: Magnetic resonance imaging (MRI) in patients with non-small cell lung cancer (NSCLC) using active breathing coordinator motion controlKaza, E. / Collins, D. / Symonds-Tayler, R. / McDonald, F. / Scurr, E. / McNair, H. / Hansen, V. / Leach, M. et al. | 2015
-
145: Retrospective review of survival outcomes for non-small cell lung cancer (NSCLC) patients treated with radical radiotherapy since 2000 in St. Bartholomew's Hospital, LondonConibear, J. / Macdougall, N. / Wells, P. et al. | 2015
-
153: Outcome of stage III inoperable non-small cell lung cancer (NSCLC) treated with radical intentShahid Iqbal, M. / Usman Saleem, M. / Peedell, C. et al. | 2015
-
160: Review of the national lung cancer audit of SCLC chemotherapy rates in Northern IrelandJohnston, R. / Watson, C. / Scullin, P. / McAleese, J. et al. | 2015
-
169: Stenting of central airway tumours with the flexible bronchoscopeVenn, R.M. / Patel, K. / Montefort, M.Z. / Hervey, S.A. / Sharma, N. / Wilkinson, J.R.W. et al. | 2015
-
188: Quality of life after treatment for brain metastases: final demographic data from the QUARTZ trialMulvenna, P. / Nankivell, M. / Barton, R. / Wilson, P. / Faivre-Finn, C. / Stephens, R. / Ardron, D. / McColl, E. / Moore, B. et al. | 2015
-
9: EGFR mutations: are exon 19 deletions and L858R different in the real world setting?Davies, R.S. / Nelmes, D. / Butler, R. / Lester, J.F. et al. | 2015
-
17: Surgery for lung cancer in nonagenarians: a new dawn approachesGhosh-Dastidar, M. / Wilson, H. / Wakelin, S. / Beesley, S. / Pilling, J. / Routledge, T. / Harrison-Phipps, K. et al. | 2015
-
108: Can a patientcarer information and support group address the unmet needs of people affected by mesothelioma?Bolton, S. / Moore, A. / Henderson, K. et al. | 2015
-
118: Has our lower local histological confirmation rate affected patient care?Abdulla, M.A. / Fisher, P.M. / Matthews, S. / Cafferty, C. / Hill, J. / Saha, S. et al. | 2015
-
129: Stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre results of the first year of treatment at BirminghamStevenson, R. / Price, L. / Webster, G. / Brennan, M. / Stange, D. / Wingate, E. / Biard, K. / Ghafoor, Q. et al. | 2015
-
141: A planning comparison study implementing ''AAA'' heterogeneity calculation algorithm for stage IIIII non-small cell lung cancer (NSCLC): is IMRT always the solution?Aznar-Garcia, L. / Wright, S. / Coppock, K. / Sridhar, T. / Ahmed, S. et al. | 2015
-
149: Correlation between graded prognostic assessment (GPA) and survival in primary lung cancer patients with brain metastases treated with stereotactic radiosurgeryLee, H. / Appel, W. / Bezecny, P. / Hindley, A. / Skailes, G. / Sivaramalingam, M. / Lau, S. / Varadarajan, K. / Benn, C. et al. | 2015
-
157: Post-operative intensity modulated radiotherapy in thymomaJackson, A.H. / Vaidya, D. / Acquah, H. / Mak, C.I. / Gore, A. et al. | 2015
-
161: Clinical experience with oral topotecan in relapsed small cell lung cancer patients following irinotecan-platinum chemotherapyBehera, D. / Maturu, V.N. / Sehgal, I.S. / Singh, N. et al. | 2015
-
22: Lung cancer diagnosed after an emergency hospital admissionConroy, K. / Miller, G. / Fuller, E. et al. | 2015
-
69: Pemetrexed in the treatment of non-small-cell lung cancerCash, R. / Dangoor, A. et al. | 2015
-
79: The East Midlands' experience in the use of crizotinib in ALK positive lung cancerChauhan, M. / Ma, N. / Ahmed, S. / Khan, S. et al. | 2015
-
85: Systemic therapy in advanced NSCLC in the older patient: a network audit of non small cell lung cancer patientsWilshaw, V. / Das, T. / Hatton, N. / Fisher, P.M. / Lee, C.E. / Danson, S.J. / Woll, P.J. / Hatton, M.Q. et al. | 2015
-
89: Recognising the valuable role a lung cancer CNS can play at the start of the patient's pathwayMaddock, N. et al. | 2015
-
99: Prospective audit of a lung cancer nurse specialist telephone link line call to surgical patients 30 days post hospital dischargeKing, M. / Nicol, E. / Magee, L.R.A. et al. | 2015
-
150: A re-audit of mortality rates after palliative radiotherapy for lung cancer from a single UK radiotherapy centreChan, C. / Faivre-Finn, C. / Bayman, N. / Burt, P.A. / Chittalia, A.Z. / Harris, M.A. / Lee, L.W. / Pemberton, L. / Sheikh, H.Y. et al. | 2015
-
158: Radical radiotherapy for non-small cell lung cancer (NSCLC) using two different modalities: single centre audit outcomeTripathi, D. / Srinivasan, D.P. / Hatton, N. / Garikipati, S.G. / Fisher, P.M. / Lee, C.E. / Mohanamurali, J. / Hatton, M.Q. et al. | 2015
-
163: Syndrome of inappropriate antidiuretic hormone (SIADH) secretion in small cell lung cancer: 12 months experience from a cancer unitBulusu, V.R. / Jessop, S. / Jeffs, Y. / Thomas, E. / Adu Poku, K. / Sa'D, A. / Prasad, B. / Azher, M. / Barclay, C. et al. | 2015
-
186: Forecasting patient recruitment for time-to-event analysis in National Lung Matrix TrialBrock, K. / Billingham, L. / Crack, L. / Popat, S. / Middleton, G. et al. | 2015
-
7: The integrin @av@b6: a new target for therapy in non-small cell lung cancerRudran, B. / Marshall, J.F. et al. | 2015
-
19: The impact of an acute oncology service on new lung cancer diagnosesWalter, H.S. / Law, A. / Bunn, C. / Nicoll, R. / Sridhar, T. / Aznar-Garcia, L. / Thomas, G. / Ahmed, S. et al. | 2015
-
26: Lung cancer fast track referrals: evaluation of a new referral form in West DorsetStirling, S. / Punwani, R. / Idris, L. / Eddie, L. / Hack, J. / Crowther, S. et al. | 2015
-
49: Success rate of local anaesthetic video assisted thoracoscopy (LAVAT) talc poudrage for malignant pleural effusions at a UK tertiary centreTufail, M. / Hussain, M. / Russell, R. / Nasimudeen, A. / Martin, N. / Panchal, R. et al. | 2015
-
53: Immunotherapy of malignant pleural mesothelioma using MET specific T-cellsThayaparan, T. / Stegen, S.J. / Parente Pereira Puri, A.C. / Petrovic, R.M. / Spicer, J. / Maher, J. et al. | 2015
-
88: Transforming lung cancer care in the community - developing and testing a new model of nursing careJeffs, Y. / Whelan, E. / Jessop, S. / Azher, M. / Thomas, E. / Bulusu, V.R. et al. | 2015
-
120: Factors affecting the risk of brain metastases following radical treatment of lung cancerAl-Ameri, A. / Craven, T. / Saltos, A. / Ghosh, D. / Snee, M. / Callister, M. et al. | 2015
-
122: Lung cancer treated using radiofrequency ablation: two year outcome dataBeeson, J. / Kaul, S. / Anikin, V. / Dalal, P. et al. | 2015
-
123: Improving lung cancer survival in Merseyside 2007-2012Kelly, V. / Maguire, J. / McIver, A. / Ledson, M. / Smyth, C. / Walshaw, M. et al. | 2015
-
171: First UK experience of robotically assisted pulmonary lobectomy using the DaVinci SISlight, R. / Bernstein, M. / Clark, S. / Stamenkovic, S. / Forty, J. et al. | 2015
-
180: Lung resection - what is high risk?Elbaroni, W. / Booth, K. / McManus, K. et al. | 2015
-
183: PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionBayman, N. / Ardron, D. / Ashcroft, L. / Baldwin, D.R. / Booton, R. / Darlison, L. / Edwards, J. / Lang-Lazdunski, L. / Lester, J.F. et al. | 2015
-
190: LungTech stereotactic body radiotherapy (SBRT) of inoperable centrally located NSCLC: a phase II study in preparation for a randomised phase III trialFalk, S. / Faivre-Finn, C. et al. | 2015